A Trusopt, Cosopt,Dorzolamide HCL CEP of the European Pharmacopoeia monograph is often referred to as a Trusopt, Cosopt,Dorzolamide HCL Certificate of Suitability (COS). The purpose of a Trusopt, Cosopt,Dorzolamide HCL CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Trusopt, Cosopt,Dorzolamide HCL EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Trusopt, Cosopt,Dorzolamide HCL to their clients by showing that a Trusopt, Cosopt,Dorzolamide HCL CEP has been issued for it. The manufacturer submits a Trusopt, Cosopt,Dorzolamide HCL CEP (COS) as part of the market authorization procedure, and it takes on the role of a Trusopt, Cosopt,Dorzolamide HCL CEP holder for the record. Additionally, the data presented in the Trusopt, Cosopt,Dorzolamide HCL CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Trusopt, Cosopt,Dorzolamide HCL DMF.
A Trusopt, Cosopt,Dorzolamide HCL CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Trusopt, Cosopt,Dorzolamide HCL CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Trusopt, Cosopt,Dorzolamide HCL suppliers with CEP (COS) on PharmaCompass.